Browsing by Author Bellet Ezquerra, Meritxell
Showing results 1 to 12 of 12
| Issue Date | Title | Author(s) |
|---|---|---|
| 12-Jan-2024 | Androgen receptor modulation: A tailored approach for oestrogen receptor-positive metastatic breast cancer | Monserrat Vicente, Laia |
| 1-Mar-2023 | Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer | Prat Aparicio, Aleix; Brasó Maristany, Fara; Martínez Sáez, Olga; Sanfeliu, Esther; Xia, Youli; Bellet Ezquerra, Meritxell; Galván, Patricia; Martínez Pérez, Debora; Pascual, Tomás; Marín Aguilera, Mercedes; Rodríguez, Ana Belén; Chic Ruché, Núria; Adamo, Barbara; Paré, Laia; Vidal, Maria; Margelí Vila, Mireia; Ballana, Ester; Gómez Rey, Marina; Oliveira, Mafalda; Felip, Eudald; Matito, Judit; Sánchez Bayona, Rodrigo; Suñol, Anna; Saura, Cristina; Ciruelos, Eva; Tolosa, Pablo; Muñoz, Montserrat; González Farré, Blanca; Villagrasa, Patricia; Parker, Joel S.; Perou, Charles M.; Vivancos, Ana |
| 17-Jun-2025 | Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial | Llombart Cussac, Antonio; Pérez García, José Manuel; Bellet Ezquerra, Meritxell; Dalenc, Florence; Gil Gil, Miguel; Ruiz Borrego, Manuel; Gavilá, Joaquín; Schmid, Peter; Zamora, Pilar; Wheatley, Duncan; Martínez de Dueñas, Eduardo; Amillano, Kepa; Di Cosimo, Serena; Antón, Antonio; Cottu, Paul-Henri; Shimizu, Eileen; Fernandez Pinto, Melissa; Sampayo Cordero, Miguel; Cortés, Javier |
| 7-Sep-2022 | High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER<sup>+</sup> breast cancer | Palafox Sánchez, Marta; Monserrat Vicente, Laia; Bellet Ezquerra, Meritxell; Villacampa, Gullermo; González Pérez, Abel; Oliveira, Mafalda; Brasó Maristany, Fara; Ibrahimi, Nusaibah; Kannan, Srinivasaraghavan; Mina, Leonardo; Herrera Abreu, Maria Teresa; Odena, Andreu; Sánchez Guixé, Mònica; Capelán, Marta; Azaro, Analía; Bruna, Alejandra; Rodriguez, Olga; Guzmán, Marta; Grueso, Judit; Viaplana, Cristina; Hernandez, Javier; Su, Faye; Lin, Kui; Clarke, Robert; Caldas, Carlos; Arribas, Joaquín; Michiels, Stefan; García Sanz, Alicia; Turner, Nicholas, 1951-; Prat Aparicio, Aleix; Nuciforo, Paolo; Dienstmann, Rodrigo; Verma, Chandra S; López Bigas, Núria; Scaltriti, Maurizio; Arnedos, Monica; Saura, Cristina; Serra Elizalde, Violeta |
| 1-Aug-2024 | Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer | Di Cosimo, Serena; Pérez García, José Manuel; Bellet Ezquerra, Meritxell; Dalenc, Florence; Gil Gil, Miguel; Ruiz Borrego, Manuel; Gavilá, Joaquín; Aguirre, Elena; Schmid, Peter; Marmé, Frederik; Gligorov, Joseph; Schneeweiss, Andreas; Albanell, Joan; Zamora, Pilar; Wheatley, Duncan; Martínez De Dueñas, Eduardo; Amillano, Kepa; Shimizu, Eileen; Sampayo Cordero, Miguel; Cortés, Javier; Llombart Cussac, Antonio |
| 9-Jul-2021 | Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study | Gil Gil, Miguel; Bellet Ezquerra, Meritxell; Bergamino Sirvén, Milana; Morales, Serafín; Barnadas, Agustí; Manso, Luis; Saura, Cristina; Fernández Ortega, Adela; Garcia Martinez, Elena; Martinez Jañez, Noelia; Melé, Mireia; Villagrasa, Patricia; Celiz, Pamela; Perez Martin, X.; Ciruelos, Eva; Pernas, Sònia |
| 18-Sep-2019 | Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial | Adamo, Barbara; Bellet Ezquerra, Meritxell; Paré, Laia; Pascual, Tomás; Vidal Losada, Maria Jesús; Pérez Fidalgo, José A.; Blanch, Salvador; Martínez, Noelia; Murillo, Laura; Gómez Pardo, Patricia; López González, Ana; Amillano, Kepa; Canes, Jordi; Galván, Patricia; González Farré, Blanca; Gonzalez, Xavier; Villagrasa, Patricia; Ciruelos, Eva; Prat Aparicio, Aleix |
| 1-May-2019 | Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication | Bellet Ezquerra, Meritxell; Ahmad, Faten; Villanueva, Rafael; Valdivia, Carolina; Palomino Doza, Julián; Ruiz, Ada; Gonzalez-Farre, Xavier; Adrover, Encarna; Azaro, Analía; Valls Margarit, Maria; Parra, Josep Lluís; Aguilar Company, Juan; Vidal Losada, Maria Jesús; Martin, Anastasi; Gavilá, Joaquín; Escrivá de Romaní, Santiago; Perelló, Antonia; Hernando, Cristina; Lahuerta, Ainhara; Zamora, Pilar; Reyes, Victoria; Alcalde, María; Masanas, Helena; Celiz, Pamela; Ruiz, Isabel; Gil Gil, Miguel; Seguí, Miquel A.; Peña, Lorena de la |
| 27-Sep-2022 | Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial | Albanell Mestres, Joan; Pérez García, José Manuel; Gil Gil, Miguel; Curigliano, Giuseppe; Ruíz Borrego, Manuel; Comerma, Laura; Gibert, Joan; Bellet Ezquerra, Meritxell; Bermejo, Begoña; Calvo, Lourdes; Haba, Juan de la; Espinosa, Enrique; Minisini, Alessandro Marco; Quiroga Garcia, Vanesa; Santaballa Bertrán, Ana; Mina, Leonardo; Bellosillo Paricio, Beatriz; Rojo, Federico; Menéndez, Silvia; Sampayo Cordero, Miguel; Popa, Crina; Malfettone, Andrea; Cortés, Javier; Llombart Cussac, Antonio |
| 3-Nov-2023 | Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer | Jhaveri, Komal L.; Bellet Ezquerra, Meritxell; Turner, Nicholas C.; Loi, Sherene; Bardia, Aditya; Boni, Valentina; Sohn, Joohyuk; Neilan, Tomas G.; Villanueva Vázquez, Rafael; Kabos, Peter; García Estévez, Laura; López Miranda, Elena; Pérez Fidalgo, J. Alejandro; Pérez García, José Manuel; Yu, Jiajie; Fredrickson, Jill; Moore, Heather M.; Chang, Ching-Wei; Bond, John W.; Eng-Wong, Jennifer; Gates, Mary R.; Lim, Elgene |
| 28-Sep-2022 | Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial | Salvador Bofill, Javier; Moreno Anton, Fernando; Rodríguez Sánchez, César A.; Galve Calvo, Elena; Hernando Melia, Cristina; Ciruelos, Eva; Vidal Losada, Maria Jesús; Jiménez Rodriguez, Begoña; De La Cruz Merino, Luis; Martínez Jañez, Noelia; Villanueva Vázquez, Rafael; De Toro Salas, Ruben; Anton Torres, Antonio; Alvarez Lopez, Isabel Manuela; Gavila Gregori, Joaquin; Quiroga Garcia, Vanesa; Vicente Rubio, Elena; De La Haba Rodriguez, Juan; Gonzalez Santiago, Santiago; Diaz Fernandez, Nieves; Barnadas Molins, Agusti; Cantos Sanchez De Ibargüen, Blanca; Delgado Mingorance, Juan Ignacio; Bellet Ezquerra, Meritxell; De Casa, Sonia; Gimeno, Asuncion; Martin, Miguel |
| 23-Apr-2021 | SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer | Pascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix |